Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Article

authors

  • Johnson, LA
  • Morgan, RA
  • Dudley, ME
  • Cassard, L
  • Yang, JC
  • Hughes, Marybeth S.
  • Kammula, US
  • Royal, RE
  • Sherry, RM
  • Wunderlich, JR
  • Lee, CC
  • Restifo, NP
  • Schwarz, SL
  • Cogdill, AP
  • Bishop, RJ
  • Kim, H
  • Brewer, CC
  • Rudy, SF
  • VanWaes, C
  • Davis, JL
  • Mathur, A
  • Ripley, RT
  • Nathan, DA
  • Laurencot, CM
  • Rosenberg, SA

publication date

  • 2009

published in

PubMed Central ID

  • pmc2929689

start page

  • 535

end page

  • 46

volume

  • 114

issue

  • 3